Evaluating outcomes of custom-made aortic devices
Official title: Results From a Multicenter Registry on the Outcomes of the Terumo Custom-made Aortic Endograft
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05777460 · Data updated 2026-11-12
This study looks at how well custom-made aortic devices work for people with thoracic aortic disease after they've had a specific repair procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Roma, RM) |
| Status | Recruiting |
| Started | October 1, 2020 |
| Main results expected | November 1, 2025 |
| Study ends | November 1, 2027 |
| Registry record updated | March 18, 2025 |
| Trial ID | NCT05777460 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with thoracic aortic disease who are not in need of urgent or emergent treatment.
✕Probably not a fit
Patients requiring urgent or emergent treatment for their aortic condition may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on assessing the mid- and long-term outcomes of patients who have undergone Thoracic Endovascular Aortic Repair (TEVAR) using custom-made devices. By monitoring these patients over time, the study aims to gather data on the effectiveness and safety of these specialized aortic devices. The study will include individuals diagnosed with thoracic aortic disease while excluding those requiring urgent or emergent treatment. The findings could provide valuable insights into the durability and performance of custom aortic devices.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of long-term outcomes for patients with aortic diseases, leading to improved treatment strategies.
How similar studies have gone: While this study focuses on custom-made devices, similar approaches in evaluating aortic repair outcomes have shown promise in previous research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Thoracic Aortic Disease Exclusion Criteria: * Urgent/Emergent treatment
Where it's running
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Rm, Italy Recruiting
Study contacts
- Study coordinator: Giovanni Tinelli
- Email: giovanni.tinelli@policlinicogemelli.it
- Phone: +39 347 4864020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating outcomes of thoracic aortic repair in patients with compromised landing zones
This study is testing different stent-graft options for patients with aortic aneurysms who have tricky anatomy to see if they can prevent complications after surgery.
-
Endovascular treatment for aortic arch pathologies in Spain
This study is testing if special stent devices can help people aged 18 to 90 with serious aortic arch problems live longer and stay safe.
-
Prospective cardiac surgery cohort to improve perioperative care
A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.
-
GORE MBA Arch Endoprosthesis Early Feasibility Study
This study tests the safety of the MBA device in people with arch-related thoracic aortic diseases to see if it can be used safely in real-world settings.
-
See if spironolactone can reduce aortic stiffness in adults with thoracic aortic aneurysm
This study tests whether spironolactone reduces aortic stiffness compared with placebo in adults with degenerative thoracic aortic aneurysms.
-
Aortic Diseases and Quality of Life: How Work Ability is Affected
This observational study tests how living with aortic diseases affects quality of life, fatigue, mental well-being, and the ability to work in adults aged 18 to 70.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.